Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 11, 2022 06:30 ET | Source: Progenity, Inc.

Progenity Announces Oral Presentation on Treatment of Gastrointestinal Disorders at 34th Belgian Week of Gastroenterology

SAN DIEGO, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today...
January 05, 2022 06:30 ET | Source: Progenity, Inc.

Progenity Announces Acceptance of Two Abstracts on Treatment of Gastrointestinal Disorders at ECCO’22

SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today...
January 03, 2022 06:30 ET | Source: Progenity, Inc.

Progenity to Participate in the H.C. Wainwright BIOCONNECT Virtual Conference

SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today...
December 20, 2021 16:05 ET | Source: Progenity, Inc.

Progenity Completes Exit from Laboratory Business with Sale of Affiliate Lab

SAN DIEGO, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today...
December 02, 2021 06:30 ET | Source: Progenity, Inc.

Progenity Announces New Patent for Single-Molecule Detection Technology

SAN DIEGO, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the fields of gastrointestinal health and oral biotherapeutics, today announced a...
November 23, 2021 06:30 ET | Source: Progenity, Inc.

Progenity Strengthens its Liquidity Position

Company received more than $44 million in warrant exercises since August 2021. Current liquidity position provides runway to achieve critical research and development milestones through 2022. SAN...
November 15, 2021 06:30 ET | Source: Progenity, Inc.

Progenity to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

SAN DIEGO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced that the company will participate in a pre-recorded fireside chat at...
November 10, 2021 16:01 ET | Source: Progenity, Inc.

Progenity Provides Corporate Update and Reports Third Quarter 2021 Financial Results

Added important patents further protecting the company’s therapeutic delivery technologiesAdded strong biotherapeutics capabilities to management team and board of directorsImplemented cost-cutting...
November 09, 2021 06:30 ET | Source: Progenity, Inc.

Progenity Appoints Adi Mohanty as Chief Executive Officer

SAN DIEGO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the appointment of Adi Mohanty as Chief Executive Officer of the...
November 04, 2021 06:30 ET | Source: Progenity, Inc.

Progenity Announces Appointment of Jill Howe to its Board of Directors

SAN DIEGO, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced the appointment of Jill Howe to its board of directors effective November...

Next Page keyboard_arrow_right